Amyris Biotechnologies creates renewable products, focusing on fuels and chemicals. The company is developing renewable fuels that reduce lifecycle (GHG) emissions 80%. The fuel source is special in that it is compatible with current gasoline engines, and can be distributed with existing petroleum infrastructure.

Amyris is also developing semi-synthetic artemisinin, a key ingredient in first-line malaria treatments, in hopes of creating a complementary source of non-seasonal, high-quality, affordable artemisinin. This source would supplement the current botanical supply, offering millions of people infected with malaria the chance to gain consistent and reliable access to lower-cost, life-saving Artemisinin-based Combination Therapies (ACTs). Amyris produces environmentally friendly chemicals for a variety of consumer products and industrial applications currently dependent on petrochemical components.

Company Growth (employees)
Type
Public
HQ
Emeryville, US
Founded
2003
Size (employees)
440 (est)+6%
Website
amyris.com
Amyris was founded in 2003 and is headquartered in Emeryville, US

Amyris Office Locations

Amyris has an office in Emeryville
Emeryville, US (HQ)
100 5885 Hollis St

Amyris Data and Metrics

Amyris Financial Metrics

Amyris's revenue was reported to be $13 m in Q1, 2017
USD

Revenue (Q1, 2017)

13 m

Gross profit (Q1, 2017)

212 k

Gross profit margin (Q1, 2017), %

2%

Net income (Q1, 2017)

(37.4 m)

EBIT (Q1, 2017)

(27.3 m)

Market capitalization (18-Aug-2017)

55.8 m

Cash (31-Mar-2017)

1.3 m
Amyris's current market capitalization is $55.8 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

41.1 m43.3 m34.2 m67.2 m

Revenue growth, %

5%(21%)97%

Cost of goods sold

38.3 m33.2 m37.4 m56.7 m

Gross profit

2.9 m10.1 m(3.2 m)10.5 m

Gross profit Margin, %

7%23%(9%)16%

R&D expense

51.4 m

Operating expense total

51.4 m

EBIT

(119.6 m)(99.8 m)(148.5 m)(95.9 m)

EBIT margin, %

(291%)(231%)(435%)(143%)

Interest expense

9.1 m28.9 m78.9 m37.6 m

Interest income

162 k387 k264 k258 k

Pre tax profit

(235.8 m)

Income tax expense

(553 k)

Net Income

(234.9 m)2.2 m(218.1 m)(97.3 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

9.3 m16.3 m7.9 m7.8 m8.6 m8.8 m9.6 m26.5 m13 m

Cost of goods sold

7.5 m10.1 m6.6 m11 m8.5 m11.2 m7.9 m14.9 m12.8 m

Gross profit

1.8 m6.2 m1.2 m(3.1 m)136 k(2.4 m)1.7 m11.7 m212 k

Gross profit Margin, %

19%38%16%(40%)2%(27%)18%44%2%

R&D expense

12.2 m12.9 m12 m11.2 m10.3 m11.9 m13.2 m12.3 m14.8 m

Operating expense total

12.2 m12.9 m12 m11.2 m10.3 m11.9 m13.2 m12.3 m14.8 m

EBIT

(24.4 m)(21.3 m)(25.2 m)(28.7 m)(31.6 m)(26.5 m)(22.9 m)(12 m)(27.3 m)

EBIT margin, %

(262%)(130%)(320%)(365%)(367%)(301%)(238%)(45%)(211%)

Interest expense

6.8 m8.6 m8.5 m46 m16.6 m8.4 m9.7 m7.9 m12.2 m

Interest income

148 k100 k86 k58 k61 k57 k82 k68 k61 k

Pre tax profit

(35.4 m)(36.5 m)(37.4 m)

Income tax expense

(125 k)(115 k)(121 k)(119 k)(138 k)(148 k)

Net Income

(35.5 m)(36.7 m)(52.3 m)(47.2 m)(76.7 m)(15.3 m)(13.6 m)(19.7 m)(37.4 m)
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

6.9 m42 m12 m27.2 m

Accounts Receivable

62.8 k

Inventories

9.5 m6.5 m5.9 m6.2 m

Current Assets

36.9 m73.6 m35.7 m59.1 m

PP&E

140.6 m119 m59.8 m53.7 m

Total Assets

198.9 m216.2 m110.2 m129.9 m

Accounts Payable

6.5 m3.5 m7.9 m15.3 m

Total Debt

128.7 m

Current Liabilities

37.3 m40 m76.8 m109.9 m

Total Liabilities

308.4 m

Additional Paid-in Capital

706.3 m724.7 m926.2 m990.9 m

Retained Earnings

(821.4 m)(819.2 m)(1 b)(1.1 b)

Total Equity

(135.8 m)(125.1 m)(158.5 m)(183.5 m)

Debt to Equity Ratio

-0.7 x

Debt to Assets Ratio

1 x

Financial Leverage

-1.5 x-1.7 x-0.7 x-0.7 x
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

88.8 m67.2 m43.8 m10.9 m10.9 m7.8 m822 k582 k1.3 m

Inventories

14.8 m16.7 m11.4 m11.1 m11.1 m7.6 m10 m7.9 m7.1 m

Current Assets

116.8 m102.9 m69.3 m36.1 m34.6 m27.7 m21.5 m21.1 m24.1 m

PP&E

140.7 m128.1 m104.5 m104 m81.9 m61.8 m65.2 m63.1 m53 m

Total Assets

284.1 m258.6 m193.1 m161.1 m135 m102.1 m105.9 m99.4 m95.4 m

Accounts Payable

8.5 m5.8 m4.6 m6.6 m11.3 m7.7 m9.8 m13.8 m16.5 m

Current Liabilities

42.4 m43.6 m51.6 m54.8 m58.8 m94.8 m129.7 m131.7 m101.6 m

Additional Paid-in Capital

717.2 m721 m727.3 m729.5 m902.9 m938.2 m949.8 m963.1 m1 b

Retained Earnings

(840.5 m)(877.2 m)(871.4 m)(918.5 m)(995.2 m)(1.1 b)(1.1 b)(1.1 b)(1.2 b)

Total Equity

(139.7 m)(180.6 m)(185.9 m)(227.8 m)(141.5 m)(156.8 m)(154.2 m)(162.5 m)(211.3 m)

Financial Leverage

-2 x-1.4 x-1 x-0.7 x-1 x-0.7 x-0.7 x-0.6 x-0.5 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(234.9 m)2.2 m(218.1 m)(97.3 m)

Depreciation and Amortization

16.6 m15 m12.9 m11.4 m

Accounts Receivable

(4.4 m)(1.2 m)4.9 m(9.3 m)

Accounts Payable

(2.6 m)(3.2 m)4.4 m6.4 m

Cash From Operating Activities

(105.9 m)(84.7 m)(85.1 m)(82.4 m)

Cash From Investing Activities

(10.3 m)(9.8 m)(5.1 m)

Cash From Financing Activities

91.2 m130.9 m61.4 m92.2 m

Interest Paid

3 m6.9 m9.4 m10 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(35.5 m)(36.7 m)(52.3 m)(47.2 m)(76.7 m)(15.3 m)(13.6 m)(19.7 m)(37.4 m)

Accounts Payable

8.5 m5.8 m4.6 m6.6 m11.3 m7.7 m9.8 m13.8 m16.5 m
USDY, 2017

Revenue/Employee

30.3 k

Financial Leverage

-0.5 x

Amyris Market Value History

Traffic Overview of Amyris

Amyris Online and Social Media Presence

Amyris Company Life and Culture

You may also be interested in